Table 1.

Frequencies of any diagnosis of COVID-19, entry to critical care and fatal outcome among those eligible for shielding, by eligibility category, up to 18 February 2021

		Diagnosed with COVID-19
	Not diagnosed with COVID-19	No critical care, non-fatal	Critical care, non-fatal	Fatal	All
All shielding categories	204,703 (96.2%)	6081 (2.9%)	359 (0.2%)	1559 (0.7%)	212,644
Shielding eligibility category
Solid organ transplant	6620 (96.3%)	188 (2.7%)	24 (0.3%)	40 (0.6%)	6872
Specific cancers	25,788 (96.6%)	652 (2.4%)	36 (0.1%)	223 (0.8%)	26,699
Severe respiratory	83,268 (96.2%)	2432 (2.8%)	131 (0.2%)	768 (0.9%)	86,599
Rare diseases	10,673 (96.4%)	300 (2.7%)	14 (0.1%)	85 (0.8%)	11,072
On immunosuppressants	30,796 (96.8%)	866 (2.7%)	42 (0.1%)	103 (0.3%)	31,807
Additional conditions	47,501 (95.8%)	1642 (3.3%)	112 (0.2%)	340 (0.7%)	49,595

Percentages are row percentages

Severe cases are those that entered critical care or were fatal